BCR/ABL induces multiple abnormalities of cytoskeletal function

Journal of Clinical Investigation

Volumn 100, Issue 1, 1997, Pages 46-57

  Salgia, Ravi ^a   Li, Jian Liang ^a   Ewaniuk, Darren S ^a   Pear, Warren ^b   Pisick, Evan ^a   Burky, Stephen A ^a   Ernst, Timothy ^a   Sattler, Martin ^a   Chen, Lan Bo ^a   Griffin, James D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Actin; Cell motility; Chronic myelogenic leukemia; Cytoskeleton; Fibronectin

Indexed keywords

ACTIN; FIBRONECTIN;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CHRONIC MYELOID LEUKEMIA; CYTOSKELETON; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

EID: 0030873021     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119520     Document Type: Article

References (36)

1. Rowley, J. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature (Lond.). 243:290-293.
2. Canellos, G.P. 1996. Diagnosis and treatment of chronic granulocytic leukemia. In Neoplastic Diseases of the Blood. P.H. Wiernik, G.P. Canellos, J.P. Dutcher, and R.A. Kyle, editors. Churchill Livingstone, Inc., New York. 65-80.
3. Gishizky, J., and O. Witte. 1992. Initiation of deregulated growth of multipotent progenitor cells by BCR-ABL in vitro. Science (Wash. DC). 256:836-839.
4. Matulonis, U., R. Salgia, K. Okuda, B. Druker, and J. Griffin. 1993. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp. Hematol. 21: 1460-1466.
5. Bedi, A., C.A. Griffin, J.P. Barber, M.S. Vala, A.L. Hawkins, S.J. Sharkis, B.A. Zehnbauer, and R.J. Jones. 1994. Growth factor-mediated terminal differentiation of chronic myeloid leukemia. Cancer Res. 54:5535-5538.
6. Bedi, A., B.A. Zehnbauer, J.P. Barber, S.J. Sharkis, and R.J. Jones. 1994. Inhibition of apoptosis by bcr-abl in chronic myeloid leukemia. Blood. 83:2038-2044.
7. Carlesso, N., J.D. Griffin, and B.J. Druker. 1994. Use of a temperature sensitive mutant to define the biological effects of the p210bcr/abl tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene. 9:149-156.
8. McWhirter, J., and J. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1533-1546.
9. Salgia, R., B. Brunkhorst, E. Pisick, J.-L. Li, S.H. Lo, L.B. Chen, and J.D. Griffin. 1995. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. Oncogene. 11:1149-1155.
10. Van Etten, R., P. Jackson, D. Baltimore, M. Sanders, P. Matsudaira, and P. Janmey. 1994. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J Cell Biol. 124: 325-340.
11. Wetzler, M., M. Talpaz, R. Van Etten, C. Hirsh-Ginsberg, M. Beran, and R. Kurzrock. 1993. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest. 92:1925-1939.
12. Renshaw, M.W., J.R. McWhirter, and J. Wang. 1995. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell Biol. 15:1286-1293.
13. Gordon, M.Y., C.R. Dowding, G.P. Riley, J.M. Goldman, and M.F. Greaves. 1987. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature (Lond.). 328:342-344.
14. Verfaillie, C.M., J.B. McCarthy, and P.B. McGlave. 1992. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J. Clin. Invest. 90:1232-1241.
15. Bazzoni, G., N. Carlesso, J.D. Griffin, and M.E. Hemler. 1996. Bcr/abl expression stimulates integrin function in hematopoietic cell lines. J. Clin. Invest. 98:521-528.
16. Daley, G., and D. Baltimore. 1988. Transformation of an interleukin-3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 BCR/ABL protein. Proc. Natl. Acad. Sci. USA. 85:9312-9316.
17. Sattler, M., R. Salgia, K. Okuda, N. Uemura, M. Durstin, E. Pisick, G. Xu, J.-L. Li, K.V. Prasad, and J.D. Griffin. 1996. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ ABL, and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene. 12:839-846.
18. Kabarowski, J., P.B. Allen, and L.M. Wiedemann. 1994. A temperature sensitive p210 bcr-abl mutant defines the primary consequences of bcr-abl tyrosine kinase expression in growth factor dependent cells. EMBO J. 13:5887-5895.
19. Salgia, R., J. Li, S.H. Lo, B. Brunkhorst, G.S. Kansas, E.S. Sobhany, Y.P. Sun, E. Pisick, M. Hallek, T. Ernst, R. Tantravahi, L.B. Chen, and J.D. Griffin. 1995. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by p210(bcr/abl). J. Biol. Chem. 270:5039-5047.
20. Salgia, R., S. Avraham, E. Pisick, J.-L. Li, S. Raja, E. Greenfield, M. Sattler, H. Avraham, and J. Griffin. 1996. The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J. Biol. Chem. 271: 31222-31226.
21. Sattler, M., M.A. Durstin, D.A. Frank, K. Okuda, K. Kaushansky, R. Salgia, and J. Griffin. 1995. The thrombopoietin receptor c-MPL activates Jak2 and TYK2 tyrosine kinases. Exp. Hematol. 23:1040-1048.
22. Chissoe, S.L., A. Bodenteich, Y.F. Wang, Y.P. Wang, D. Burian, S.W. Clifton, J. Crabtree, A. Freeman, K. Iyer, J.A. Li, Y.C. Ma, H.J. Mclaury, H.Q. Pan, O.H. Sarhan, S. Toth, Z.L. Wang, G.Z. Zhang, N. Heisterkamp, J. Groffen, and B.A. Roe. 1995. Sequence and analysis of the human abl gene, the bcr gene, and regions involved in the Philadelphia chromosomal translocation. Genomics. 27:67-82.
23. Lugo, T., A. Pendergast, A. Muller, and O. Witte. 1990. Tyrosine kinase activity and transformation potency of bcr/abl oncogene products. Science (Wash. DC). 247:1079-1082.
24. Daley, G.Q., J. McLaughlin, O.N. Witte, and D. Baltimore. 1987. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science (Wash. DC). 237:532-535.
25. Fainstein, E., C. Marcelle, A. Rosner, E. Canaani, R.P. Gale, O. Dreazen, S.D. Smith, and C.M. Croce. 1987. A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature (Lond.). 330:386-388.
26. Walker, L.C., T.S. Ganesan, S. Dhut, B. Gibbons, T.A. Lister, J. Rothbard, and B.D. Young. 1987. Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature (Lond.). 329:851-853.
27. McWhirter, J., and J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell Biol. 11:1553-1565.
28. Pedersen, T., K. Yong, J. Pedersen, N. Hansen, K. Dano, and T. Plesner. 1996. Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal haemoglobinuria. Br. J. Haematol. 95:45-51.
29. Levesque, J.P., D.N. Haylock, and P.J. Simmons. 1996. Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34 (+) hemopoietic progenitors. Blood. 88:1168-1176.
30. Verma, D., G. Spitzer, J. Gutterman, A. Zander, K. McCradie, and K. Dicke. 1979. Human leukocyte interferon preparation blocks granulopoietic differentiation. Blood. 54:1423-1427.
31. Talpaz, M., H.M. Kantarjian, K. McCredie, J.M. Trujillo, M.J. Keating, and J.U. Gutterman. 1986. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N. Engl. J. Med. 314:1065-1069.
32. Bhatia, R., E.A. Wayner, P.G. McGlave, and C.M. Verfaillie. 1994. Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. J. Clin. Invest. 94:384-391.
33. Bhatia, R., J. McCarthy, and C. Verfaillie. 1996. Interferon-α restores normal β1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood. 87:3883-3891.
34. Yamaguchi, R., M. Maki, M. Hatanaka, and H. Sabe. 1994. Unphosphorylated and tyrosine-phosphorylated forms of a focal adhesion protein, paxillin, are substrates for calpain ii in vitro-implications for the possible involvement of calpain ii in mitosis-specific degradation of paxillin. FEBS Lett. 356:114-116.
35. Salgia, R., N. Uemura, K. Okuda, J.-L. Li, E. Pisick, M. Sattler, R. de-Jong, B. Druker, N. Heisterkamp, L. Chen, J. Groffen, and J. Griffin. 1995. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J. Biol. Chem. 270:29145-29150.
36. Salgia, R., M. Sattler, E. Pisick, J.-L. Li, and J. Griffin. 1996. p210BrR/ ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-CBL. Exp. Hematol. 24:310-313.